Company Profile
CG Oncology, Inc. Stock Price, News & Analysis
- Ticker:
- CGON
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, CG Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Stock performance
65.73 USD (-0.78%)
Close
Last updated: June 23, 2026 at 00:00
5.8B USD
Market cap
Why the stock is moving
CGON is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
CG Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, CG Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock.
Business Model Characteristics
CG Oncology follows a pipeline-and-commercial model where investors track trial execution, launch cadence, and the pace at which oncology data can be turned into durable product value.
Position Within the Biotechnology Landscape
Compared with larger diversified peers, CG Oncology sits in a high-catalyst corner of the biotech landscape, where oncology updates can reprice the stock quickly.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of CG Oncology, Inc. (CGON)?
CG Oncology, Inc. (CGON) most recently closed at 65.73 USD, a -0.78% move versus the previous session.
What is the market cap of CG Oncology, Inc. (CGON)?
CG Oncology, Inc. currently has a market capitalization of 5.8B USD on BioPharmSignal.
What does CG Oncology, Inc. do?
CG Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
On which exchange is CGON stock listed?
CG Oncology, Inc. (CGON) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, CG Oncology is followed within the oncology universe where readouts and regulatory timing often dominate the stock., Biotechnology.
What is Oncology?
CG Oncology is an oncology-focused biopharmaceutical company centered on cancer programs, with investors watching clinical data, regulatory milestones, and the commercial path for its lead assets.
Which conditions is CG Oncology, Inc. targeting with Oncology?
CG Oncology, Inc. is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.